Special Issue "Advances in Molecular Research on Antibacterial Nanoparticles"
Deadline for manuscript submissions: 30 March 2024 | Viewed by 137
The development of multi-drug resistance (MDR) in different bacterial strains (Enterococci, Staphylococci, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter species) has become a serious threat over the globe. Numerous antibacterial agents have been developed; however, with the rise of MDR in bacteriological species, the therapeutic efficacy of currently available antibiotics and antibacterial agents is at risk. According to the World Health Organization (WHO), bacterial infections now cause 0.7 million lives each year. If we do not discover effective treatments to manage or eliminate these MDR bacteria, this figure might climb to ten million by 2050. Therefore, this has become obligatory to find alternate routes to tackle these MDR pathogenic microbes.
Nanotechnology, a promising and revolutionary field, has garnered much interest for its potential to address these issues. Nanotechnology is an interdisciplinary field of study that leverages fundamental concepts from many areas, such as biology, physics, engineering, and chemistry, to create unique approaches for manipulating minute particles, culminating in the fabrication of nanoparticles (NAPs). NAPs (metal, metal oxides, polymer-based, etc.) synthesized by various methods (chemical, physical, green, etc.) are widely used as antibacterial agents in catheter coatings, medical equipment disinfection, filters, dental hygiene, eye care, and topical ointments.
Antibacterial NAPs function by circumventing bacterial MDR mechanisms and reducing biofilm formation or other vital processes associated with their pathogenicity potential. Antibacterial NAPs are capable of penetrating the bacterial cell wall and membrane and interrupting vital molecular pathways. In conjunction with suitable antibiotics, they may exhibit synergy and aid in preventing the escalating MDR threat on a worldwide scale.
We invite researchers to contribute reviews, original research articles, and communications on molecular research on antibacterial nanoparticles, which will highlight the most innovative and exciting advancements in this area.
Dr. Shakeel Ahmad Khan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biofilm inhibition
- multi-drug resistance